Reassessment of global benefit-risk assessment of antidepressants: venlafaxine XR and fluoxetine.
作者信息
Tamura Roy N, Lu Yili
出版信息
J Psychiatr Res. 2003 Mar-Apr;37(2):175-6; author reply 176-7. doi: 10.1016/s0022-3956(02)00090-0.
Abstract
摘要
相似文献
1
Reassessment of global benefit-risk assessment of antidepressants: venlafaxine XR and fluoxetine.
J Psychiatr Res. 2003 Mar-Apr;37(2):175-6; author reply 176-7. doi: 10.1016/s0022-3956(02)00090-0.
2
Global benefit-risk assessment of antidepressants: venlafaxine XR and fluoxetine.
J Psychiatr Res. 2002 May-Jun;36(3):111-8. doi: 10.1016/s0022-3956(01)00055-3.
3
Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study Group.
J Clin Psychiatry. 1999 Jan;60(1):22-8. doi: 10.4088/jcp.v60n0105.
4
Once-daily venlafaxine extended release (XR) vs. fluoxetine for the treatment of depression.
J Affect Disord. 2001 Sep;66(1):95-8. doi: 10.1016/s0165-0327(00)00257-3.
5
Venlafaxine versus fluoxetine.
J Clin Psychiatry. 1999 Oct;60(10):708. doi: 10.4088/jcp.v60n1016.
6
Venlafaxine-fluoxetine-nortriptyline interaction.
J Psychiatry Neurosci. 1997 Jul;22(4):278-9.
7
Combining antidepressant medications: a good idea?
Am J Psychiatry. 2010 Mar;167(3):241-3. doi: 10.1176/appi.ajp.2009.09121768.
8
Duloxetine compared with fluoxetine and venlafaxine: use of meta-regression analysis for indirect comparisons.
BMC Psychiatry. 2006 Jul 24;6:30. doi: 10.1186/1471-244X-6-30.
9
Venlafaxine-fluoxetine interaction.
J Clin Psychopharmacol. 1999 Feb;19(1):96-8. doi: 10.1097/00004714-199902000-00017.
10
Acute and continuation treatment adequacy with venlafaxine extended release compared with fluoxetine.
Pharmacotherapy. 2004 Jan;24(1):33-40. doi: 10.1592/phco.24.1.33.34807.
Zotero 插件